Gastrointestinal malignant melanoma：a report of 2 cases and review of literature

Chao Shen,Yingjiang Ye,Yichao Yan,Yang Yang,Dafang Liu,Tao Li,Shan Wang,Bin Liang

DOI: https://doi.org/10.3877/cma.j.issn.1674-0785.2014.24.009

2014-01-01

Abstract:Objective To analyze the character of epidemiology, pathogenesis, clinical manifestation, pathology and therapy of gastrointestinal malignant melanoma (GIMM). Methods Two cases of GIMM in Peking University People’s Hospital were reported and literatures were reviewed. Results Both two male patients were diagnosed with malignant melanoma pathologically with a course within 1 year. Both had chemotherapy after surgery. No recurrence of 24 months occurred in one patient. Metastatic GIMM was common while primary GIMM was rare. Metastatic GIMM could occur several years after the primary site was removed. About 4% to 12% metastatic GIMM had no definite primary cancer. The most common clinical features were intermittent abdominal pain, anemia, weight loss and abdomen mass. Surgery was the most important treatment. The main influence factors of surgery were to choose the appropriate patients and to undergo radical resection. Early diagnosis and radical resection could improve the prognosis of patients. Age, tumor location and size, the location of primary lesion and whether to have radical resection or not were independent prognostic factors, as well as the interval from removing the primary cancer to metastatic GIMM. Combing target drugs and immune targeting drugs were new directions of researches of melanoma in the future. Conclusion GIMM has poor prognosis and early distant metastasis. It is difficult to diagnose early, so it is necessary to have an overall examination for melanoma patients with gastrointestinal symptoms. Patients of isolate lesion should undergo active radical resection and auxiliary drug treatment after surgery.